Addiction Research

According to the World Health Organization (WHO), addiction is 'a chronic disease of the central nervous system that is characterized by a loss of control over impulsive behavior that leads to compulsive drug seeking and taking, and to relapses even after months of abstinence'. Addiction is a complex neuroadaptive process, where drugs of abuse alter cellular and molecular aspects of neural function. The brain circuits mediating the various behavioral effects of these drugs are rendered more, or less, responsive to those effects.

Addiction Research Products Targets

Products for Addiction Research - Page 45

Cat.No. Product Name Information/Activity
BCC7292 N20C hydrochloride 1177583-87-7
BCC4504 Nefiracetam Nefiracetam is a GABAergic, cholinergic, and monoaminergic neuronal systems enhancer for Ro 5-4864-induced convulsions.
BCC2676 H-D-Ser-OH (R)-Serine, an endogenous amino acid involved in glia-synapse interactions that has unique neurotransmitter characteristics, is a potent co-agonist at the NMDA glutamate receptor. (R)-Serine has a cardinal modulatory role in major NMDAR-dependent processes including NMDAR-mediated neurotransmission, neurotoxicity, synaptic plasticity, and cell migration.
BCC6864 Spermine tetrahydrochloride Spermine tetrahydrochloride is an endogenous metabolite.
BCC6143 AR-M 1000390 hydrochloride AR-M 1000390 hydrochloride is an exceptionally selective, potent δ opioid receptor agonist with an EC50 of 7.2±0.9 nM for δ agonist potency.
BCC5798 BW 373U86 155836-50-3
BCC6064 DADLE 63631-40-3
BCC6233 Deltorphin I Deltorphin I is a δ-opioid receptor agonist with high affinity and selectivity.
BCC5723 [D-Ala2]-Deltorphin II Deltorphin 2 is a selective peptide agonist for the δ opioid receptor.
BCC5758 DPDPE 88373-73-3